title: Predicting the Durability of Biological Therapy in Pediatric Crohn's Disease: Do the Immunomodulators Matter?
authors.affiliation: Department of Pediatrics and Childhood Neuropsychiatry, Sapienza University of Rome, Italy; Pediatric Gastroenterology, Hepatology and Digestive Endoscopy Unit, University Hospital Umberto I, Rome, Italy.
authors.forename: Marina
authors.initials: M
authors.lastname: Aloi
authors.affiliation: Department of Pediatrics and Childhood Neuropsychiatry, Sapienza University of Rome, Italy; Pediatric Gastroenterology, Hepatology and Digestive Endoscopy Unit, University Hospital Umberto I, Rome, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cucchiara
mesh_terms: D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069285:Infliximab / Q000008:administration & dosage*; D008297:Male
chemical_list: D007155:Immunologic Factors; D000069285:Infliximab